Plasma Glutathione and Prodromal Parkinson's Disease Probability

ABSTRACT Background A decrease in glutathione (GSH) levels is considered one of the earliest biochemical changes in Parkinson's disease (PD). Objective The authors explored the potential role of plasma GSH as a risk/susceptibility biomarker for prodromal PD (pPD) by examining its longitudinal a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Movement disorders 2022-01, Vol.37 (1), p.200-205
Hauptverfasser:	Charisis, Sokratis, Ntanasi, Eva, Stamelou, Maria, Xiromerisiou, Georgia, Maraki, Maria, Veskoukis, Aristidis S., Yannakoulia, Mary, Kosmidis, Mary H., Anastasiou, Costas A., Giagkou, Nikolaos, Dardiotis, Efthimios, Hadjigeorgiou, Georgios, Sakka, Paraskevi, Kouretas, Demetrios, Stefanis, Leonidas, Scarmeas, Nikolaos
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Basal ganglia Central nervous system diseases Glutathione Glutathione - blood Humans Movement disorders Neurodegenerative diseases Oxidative stress Parkinson Disease - blood Parkinson Disease - diagnosis Parkinson's disease Plasma plasma glutathione Probability prodromal Parkinson's disease Prodromal Symptoms redox biomarkers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!